|
|
|
| Clinical effect of ultrasound-guided percutaneous taxol coated balloon dilation in the treatment of internal arteriovenous fistula stenosis |
| ZHANG Ce ZHOU Feihong XU Xiaohong WANG Junsheng |
Department of Nephrology, Nanjing Gulou Hospital Group Suqian Hospital, Jiangsu Province, Suqian 223800, China
|
|
|
|
Abstract Objective To investigate the clinical effect of ultrasound-guided percutaneous taxol coated balloon dilation in the treatment of internal arteriovenous fistula stenosis. Methods A total of 112 patients with internal arteriovenous fistula stenosis in the Department of Nephrology, Nanjing Gulou Hospital Group Suqian Hospital from December 2020 to December 2022 were selected and divided into general group and drug group according to random number table method, with 56 patients in each group. Ultrasound-guided percutaneous selective balloon dilatation was performed in both groups, in which the conventional group was dilated by conventional balloon and the drug group was dilated by taxol coated balloon. The stenosis diameter and dialysis blood flow of the two groups were compared before and one week after surgery. The success rate and complication rate of the two groups were evaluated one month after surgery, and the total incidence of restenosis of the two groups was evaluated at nine months after surgery. Results At one week after surgery, the stenosis diameter and dialysis blood flow in two groups were higher than those before surgery, and those of the drug group were higher than those of general group (P＜0.05). The success rate of surgery in drug group was higher than that in general group (P＜0.05). There was no significant difference in the total incidence of complications between the two groups (P＞0.05). At nine months after surgery, the total incidence of restenosis in the drug group was lower than that in the general group (P＜0.05). Conclusion Ultrasound-guided percutaneous taxol coated balloon dilation in patients with internal arteriovenous fistula stenosis can improve the stenosis diameter and dialysis blood flow, improve the success rate of surgery, reduce the rate of postoperative restenosis, and have high safety.
|
|
|
|
|
|
[1] Farrington CA，Cutter G，Allon M. Arteriovenous Fistula Nonmaturation：What’s the Immune System Got to Do with It？[J] Kidney360，2021，2（11）：1743-1751.
[2] Vazquez-Padron RI，Duque JC，Tabbara M，et al. Intimal Hyperplasia and Arteriovenous Fistula Failure：Looking Beyond Size Differences [J]. Kidney360，2021，2（8）：1360-1372.
[3] 叶倩呈，王三营，刘倩影，等.维持性血液透析患者自体动静脉内瘘失功风险预测模型的研究进展[J].中国护理管理，2022，22（7）：1102-1105.
[4] 马孝芬，刘乃全，高树熹，等.超声引导下经皮球囊扩张血管成形术治疗自体动静脉内瘘狭窄的自身对照研究[J].中国临床医学影像杂志，2021，32（8）：561-564.
[5] Sakata KK，Nelson DR，Mullon JJ，et al. Paclitaxel-coated balloon dilation for central airway obstruction [J]. Respir Med Case Rep，2018，16（24）：129-132.
[6] 肖雪，吴海燕，李蓬，等.超声下球囊扩张术对自体动静脉内瘘狭窄患者再狭窄发生率的影响[J].山西医药杂志，2020，49（10）：1254-1256.
[7] 张童，庄百溪，石波，等.紫杉醇药物涂层球囊与普通球囊治疗腘动脉粥样硬化闭塞性病变的疗效比较[J].中华普通外科杂志，2017，32（12）：1026-1029.
[8] Vos NS，Fagel ND，Amoroso G，et al. Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction：The REVELATION Randomized Trial [J]. JACC Cardiovasc Interv，2019，12（17）：1691-1699.
[9] 中国医院协会血液净化中心分会血管通路工作组.中国血液透析用血管通路专家共识（第2版）[J].中国血液净化，2019，18（6）：365-381.
[10] Stegmayr B，Willems C，Groth T，et al. Arteriovenous access in hemodialysis：A multidisciplinary perspective for future solutions [J]. Int J Artif Organs，2021，44（1）：3-16.
[11] Burnett CT，Nicholls G，Swinbank A，et al. Cephalic arch stenosis in the arteriovenous fistula：A retrospective analysis of predisposing factors [J]. J Vasc Access，2022，21（10）：11297298211067848.
[12] Alturkistani HM，Alsergani AH，Alasqah MI，et al. Predictors of recurrent arteriovenous fistula stenosis in Saudi patients undergoing hemodialysis [J]. Saudi Med J，2022，43（6）：592-598.
[13] Lindhard K，Rix M，Heaf JG，et al. Effect of far infrared therapy on arteriovenous fistula maturation，survival and stenosis in hemodialysis patients，a randomized，controlled clinical trial：the FAITH on fistula trial [J]. BMC Nephrol，2021，22（1）：283.
[14] Gregory M，Guest M，Abdeen I，et al. Balloon assisted，ultrasound guided percutaneous thrombin injection of a large radial artery pseudoaneurysm using a trans-venous approach via an Ipsilateral Arteriovenous Fistula [J]. CVIR Endovasc，2021，4（1）：67.
[15] 卢松芳，陈靖，马鹏跃，等.超声引导下二次经皮腔内血管成形术治疗动静脉内瘘术后再狭窄效果观察[J].山东医药，2020，60（20）：55-57.
[16] 成宜舜，栾丽芹，张曦，等.急诊支架植入或单纯球囊成形对颅内动脉粥样硬化狭窄相关急性缺血性脑卒中患者转归的影响[J].中国临床研究，2023，36（3）：325-328.
[17] 丁铃，张青松，李永才，等.药物洗脱球囊治疗冠状动脉小血管病变的临床疗效[J].中西医结合心脑血管病杂志，2020，18（20）：3441-3443.
[18] 陈飞，杨秀春，鲁静朝，等.药物涂层球囊与药物洗脱支架治疗冠状动脉支架内再狭窄疗效分析[J].河北医药，2020，42（7）：1051-1053，1057.
[19] 林越，洪翔，郭大乔，等.药物涂层球囊联合支架植入与普通球囊联合支架植入治疗股腘动脉TASC D级病变的疗效比较[J].中华普通外科杂志，2022，37（1）：21-25.
[20] 陈韵岱.药物涂层球囊在冠心病介入治疗中的应用现状[J].中国心血管杂志，2020，25（2）：101-103.
[21] 张恺欣，张明，陈军，等.药物涂层球囊扩张与经皮腔内球囊扩张合并支架植入术对下肢动脉硬化闭塞病变患者治疗的各项临床指标的影响[J].河北医学，2022，28（6）：960-964.
[22] 尹秋林，曾林飞，邓志芳，等.血管内超声及光学相干断层扫描成像指导下药物球囊治疗在冠脉原位病变中的应用[J].中国当代医药，2022，29（34）：89-92.
[23] 张大鹏，王乐丰，刘宇，等.药物涂层球囊与药物洗脱支架治疗冠状动脉原发病变的疗效与安全性比较[J].中华心血管病杂志，2020，48（7）：600-607.
[24] 赵宇.紫杉醇药物涂层球囊主动保护技术在冠状动脉分叉病变介入治疗中的应用[D].北京：中国人民解放军总医院;解放军医学院，2017.
[25] AbiMansour JP，Abu DB，Levy MJ，et al. Percutaneous transluminal angioplasty balloons for endoscopic ultrasound- guided pancreatic duct interventions [J]. World J Gastrointest Endosc，2022，14（8）：487-494.
[26] Jin W，Song Y，Fei X. The Pros and cons of balloon dilation in totally ultrasound-guided percutaneous Nephrolithotomy [J]. BMC Urol，2020，20（1）：82.
[27] 王硕，孙爱，张慧杰，等.心肌缺血预适应在紫杉醇释放冠脉球囊导管扩张术中的应用[J].昆明医科大学学报，2021，42（12）：89-94.
[28] 崔世军，郭连瑞，齐一侠，等.紫杉醇药物涂层球囊扩张结合球囊扩张支架成形治疗动脉硬化性肾动脉狭窄1例报告[J].中国微创外科杂志，2019，19（1）：93-94. |
|
|
|
